Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Menstrual Migraines: Effects of Continuous Oral Contraceptives to Combination With Prophylactic Frovatriptan Use During Hormone Free Intervals

NCT00700128 is registered in ClinicalTrials.gov with Scott and White Hospital & Clinic as lead sponsor.

NCT NCT00700128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00700128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Menstrual Migraines: Effects of Continuous Oral Contraceptives to Combination With Prophylactic Frovatriptan Use During Hormone Free Intervals
Lead sponsor
Scott and White Hospital & Clinic
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2008
Completion date
January 31, 2010
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, migraines, spotting